Quality of life is an important indication for second-line treatment in children with immune thrombocytopenia.

Kristin A Shimano Cindy E Neunert James B Bussel Robert J KlaassenRukhmi BhatYves D PastoreMichele P Lambert Carolyn M BennettJenny M DespotovicPeter ForbesRachael F Grace

Published in: Pediatric blood & cancer (2021)

Perceived QOL is the most frequently selected reason pediatric patients start second-line therapies for ITP. It is critical that studies of treatments for childhood ITP include assessments of their effects on QOL.

Keyphrases

young adults
depressive symptoms
social support
physical activity
mental health
early life
case control
replacement therapy